Company Filing History:
Years Active: 2012
Title: Innovations of Phillip C C Liu in Cancer Treatment
Introduction
Phillip C C Liu is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of cancer treatment, particularly through his innovative research and patents. His work focuses on the modulation of Her-2 cleavage, which plays a crucial role in breast cancer therapies.
Latest Patents
Phillip C C Liu holds a patent for "Compositions, methods and kits relating to Her-2 cleavage." This invention relates to compositions and methods based on the ADAM-mediated cleavage of Her-2. It also addresses treatments for cancer, specifically breast cancer, by modulating this cleavage. The invention highlights the synergistic effect between the inhibition of Her-2 cleavage by an ADAM and certain cytostatic and cytotoxic compounds, which can inhibit tumor cell proliferation and induce cell death. Additionally, Liu's patent includes novel variants of ADAM15, designated as ADAM15 variant 1 and ADAM15 variant 2, which have been identified and isolated.
Career Highlights
Phillip C C Liu is associated with Incyte Corporation, where he continues to advance his research in cancer treatment. His work has been instrumental in developing new therapeutic strategies that leverage the mechanisms of Her-2 cleavage.
Collaborations
Liu has collaborated with notable colleagues such as Steven M Friedman and Peggy Ann Scherle. These partnerships have contributed to the advancement of his research and the development of innovative cancer treatments.
Conclusion
Phillip C C Liu's contributions to cancer treatment through his patent on Her-2 cleavage exemplify the impact of innovative research in the medical field. His work continues to pave the way for new therapeutic approaches in combating breast cancer.